BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Diagnosis
9 results:

  • 1. Time intervals and previous primary care consultations in the pathway to emergency cancer diagnosis.
    Bosch X; Montori-Palacin E; Calvo J; Carbonell I; Naval-Álvarez J; Moreno P; López-Soto A
    Cancer Epidemiol; 2023 Oct; 86():102445. PubMed ID: 37651939
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.
    Zhao R; Ren S; Li C; Guo K; Lu Z; Tian L; He J; Zhang K; Cao Y; Liu S; Li D; Wang Z
    Cancer Med; 2023 Feb; 12(4):5158-5171. PubMed ID: 36161527
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A nomogram-based model and ultrasonic radiomic features for gallbladder polyp classification.
    Zhang X; Wang J; Wu B; Li T; Jin L; Wu Y; Gao P; Zhang Z; Qin X; Zhu C
    J Gastroenterol Hepatol; 2022 Jul; 37(7):1380-1388. PubMed ID: 35357026
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced pancreatic cancer Undergoing Resection.
    Ren W; Xourafas D; Ashley SW; Clancy TE
    Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.
    McLellan P; Henriques J; Ksontini F; Doat S; Hammel P; Desrame J; Trouilloud I; Louvet C; Pietrasz D; Vernerey D; Bachet JB
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101541. PubMed ID: 33055007
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the diagnosis of pancreatic Ductal Adenocarcinoma.
    Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
    Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) performed in patients with Periampullary duodenal diverticula (PAD).
    Zippi M; Traversa G; Pica R; De Felici I; Cassieri C; Marzano C; Occhigrossi G; Paoluzi P
    Clin Ter; 2014; 165(4):e291-4. PubMed ID: 25203345
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
    Tomimaru Y; Takeda Y; Tatsumi M; Kim T; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Nagano H; Umeshita K; Wakasa K; Doki Y; Mori M
    Oncol Rep; 2010 Sep; 24(3):613-20. PubMed ID: 20664965
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.